| Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
|---|
| 01/26/2005 | CN1569228A SARS vaccine and its preparation method and application |
| 01/26/2005 | CN1569227A A fusion protein contraception vaccine with molecular adjuvant and its preparation |
| 01/26/2005 | CN1186445C Light chain or heavy chain variable region gene of human liver cancer monoclonal antibody HAb18 and its application |
| 01/25/2005 | US6846912 Monoclonal antibody specific for leukocyte antigen related (LAR) phosphatase for diagnosis and treatment of thyroid cancer insulin resistance and arteriosclerosis |
| 01/25/2005 | US6846911 An isolated protein comprising a soluble CD97 alpha subunit, and soluble subunit is selected from the group alpha 1, alpha 2, and alpha 3, originate as proprotein with beta subunit |
| 01/25/2005 | US6846908 DCR-5 bone affecting ligand |
| 01/25/2005 | US6846907 Osteoporosis treatment |
| 01/25/2005 | US6846905 Antigen constructs useful in the detection and differentiation of antibodies to HIV |
| 01/25/2005 | US6846803 Hybrid polynucleotide |
| 01/25/2005 | US6846799 Administering epidermal growth factor antagonist; blocking with antibody; chronic obstructive pulmonary disease |
| 01/25/2005 | US6846674 Gene, encoding a subunit of the transcription factor AP-1, of its genome is inactivated and/or a component, acting on the AP-1 transcription factor, of the signal transduction pathway is modified resulting in a modified AP-1 activity and |
| 01/25/2005 | US6846667 Virulence genes and proteins, and their use |
| 01/25/2005 | US6846652 As vaccines and anticancer agents |
| 01/25/2005 | US6846651 Comprises sequence of influenza bacterial genome and position of proteins relative to specific restriction enzyme; diagnosis and treatment of respiratory disorders; genetic mapping |
| 01/25/2005 | US6846650 Nucleotide sequences coding polypeptide for use in the imaging, diagnosis, treatment classification and prevention of lung cancer |
| 01/25/2005 | US6846622 Tagged epitope protein transposable element |
| 01/25/2005 | US6846489 Vaccines containing a saponin and a sterol |
| 01/25/2005 | US6846487 Therapeutic compositions for treating infection by Lawsonia spp. |
| 01/25/2005 | US6846486 Vaccine; therapy, prevention asthma; mixture of antihistamine antibody and interferons; antiallergens |
| 01/25/2005 | US6846481 Recombinant expression of heterologous nucleic acids in protozoa |
| 01/25/2005 | US6846477 One dose vaccination with Mycoplasma hyopneumoniae |
| 01/25/2005 | US6846476 Treatment of B-cell associated diseases |
| 01/25/2005 | CA2435967A1 Reovirus for the treatment of lymphoid malignancies |
| 01/25/2005 | CA2146442C Anti-inflammatory factor, method of isolation, and use |
| 01/25/2005 | CA2133108C Pasteurella haemolytica type a-1 bacterin-toxoid vaccine |
| 01/25/2005 | CA2123224C Murine monoclonal antibody (5c8) recognizes a human glycoprotein on the surface of t-lymphocytes |
| 01/20/2005 | WO2005005954A2 Method, composition and kit for detecting phosphatidylserine (ps) on cell membranes |
| 01/20/2005 | WO2005005651A2 T cell receptor sequence and method for detecting and treating rheumatoid arthritis |
| 01/20/2005 | WO2005005631A1 Hla-a24 binding cancer antigen peptide derived from ribin |
| 01/20/2005 | WO2005005630A2 Therapeutic use of lpi, a staphylococcal lectin pathway inhibitor in inflammatory diseases |
| 01/20/2005 | WO2005005625A2 Method for inducing hepatitis c virus (hcv) replication in vitro, cells and cell lines enabling robust hcv replication and kit therefor |
| 01/20/2005 | WO2005005623A1 Method for lysys for tumor cells |
| 01/20/2005 | WO2005005620A1 Autologous self-tolerance inducing cells of monocytic origin and their use in pharmaceutical proparations |
| 01/20/2005 | WO2005005614A2 Combined b-cell and t-cell epitopes on vlp for improved vaccines |
| 01/20/2005 | WO2005005603A2 Method for inducing an immune response to cancer antigen |
| 01/20/2005 | WO2005005596A2 Characterization of the earliest stages of the severe acute respiratory syndrome (sars) virus and uses thereof |
| 01/20/2005 | WO2005005481A2 Combination therapy for gastroenteric diseases caused by microorganisms |
| 01/20/2005 | WO2005005472A1 Use of a novel eimeria gene and corresponding protein |
| 01/20/2005 | WO2005005467A2 Novel immune booster compound comprising an ef adenoviral sequence |
| 01/20/2005 | WO2005005465A2 Methods and compositions to enhance immune responses via recall antigens |
| 01/20/2005 | WO2005005462A2 Blys antagonists and uses thereof |
| 01/20/2005 | WO2005004911A2 Adjuvant combinations of liposomes and mycobacterial lipids for immunization compositions and vaccines |
| 01/20/2005 | WO2005004910A2 Hcv vaccines |
| 01/20/2005 | WO2005004909A2 Method of enhanced immunogenicity to meningococcal vaccination |
| 01/20/2005 | WO2005004908A1 Ultrafiltration for preparing outer membrane vesicles |
| 01/20/2005 | WO2005004907A1 Packaged virus-like particles |
| 01/20/2005 | WO2005004904A1 Method for treating diseases associated with modifications of qualitative and/ quantitative composition of blood extracellular dna (variants) |
| 01/20/2005 | WO2005004893A2 Inhibition of stress-induced ligand-dependent egfr activation |
| 01/20/2005 | WO2005004809A2 Multivalent carriers of bi-specific antibodies |
| 01/20/2005 | WO2005004800A2 Trypanosome derived apoptotic factors (taf) |
| 01/20/2005 | WO2005004793A2 Compositions and methods for treating coagulation related disorders |
| 01/20/2005 | WO2005004791A2 Compounds and methods for the treatment and prevention of bacterial infection |
| 01/20/2005 | WO2004106411A3 Biodegradable poly(beta-amino esters) and uses thereof |
| 01/20/2005 | WO2004093909A9 Methods to regulate biofilm formation |
| 01/20/2005 | WO2004092208A3 Sars-related proteins |
| 01/20/2005 | WO2004089983A3 Severe acute respiratory syndrome (sars) causing coronavirus |
| 01/20/2005 | WO2004087207A3 Method for inducing apoptosis and aneuploidy regression in cancer cells |
| 01/20/2005 | WO2004083382A3 Compositions and methods for treating hyperimmune response in the eye |
| 01/20/2005 | WO2004069142A3 Anti-candida agents for the treatment of prion diseases |
| 01/20/2005 | WO2004048925A3 NaCT AS A TARGET FOR LIFESPAN EXPANSION AND WEIGHT REDUCTION |
| 01/20/2005 | WO2004034995A3 Methods and reagents for inducing immunity |
| 01/20/2005 | WO2004026265A3 Compositions and methods for treatment of herpesvirus infections |
| 01/20/2005 | WO2004022590A3 Immunogenic muc1 glycopeptides |
| 01/20/2005 | WO2003066881A3 Therapeutic polypeptides, nucleic acids encoding same, and methods of use |
| 01/20/2005 | WO2003057155A3 Monoclonal antibody imaging and therapy of tumors that express met and bind hepatocyte growth factor |
| 01/20/2005 | WO2003035848A9 Ibc-1 (invasive breast cancer-1), a putative oncogene amplified in breast cancer |
| 01/20/2005 | US20050015039 Inhibition of HIV-1 replication by disruption of the processing of the viral capsid-spacer peptide 1 protein |
| 01/20/2005 | US20050014934 Modified immunoglobulin receptor for use as enhanced indicator tool immunological detection; protein detection |
| 01/20/2005 | US20050014931 A monoclonal antibody or an antigen-binding fragment thereof that specifically binds the capsular polysaccharide of Streptococcus pneumoniae serotype PPS 3; heavy chain amino acid sequence as well as DNA encoding it; complementary determining regions; pneumonia; passive immunizations; diagnosis/medical/ |
| 01/20/2005 | US20050014734 Stabilization concentration of interleukins; lupus; antiarthritic agents; anticancer agents; antiallergens; skin disorders; aids |
| 01/20/2005 | US20050014733 Therapeutic and prophylactic methods for neuromuscular disorders |
| 01/20/2005 | US20050014718 Tumor specific oligosaccharide sequences and use thereof |
| 01/20/2005 | US20050014692 Isolate nucleic acids; intensify stimulated insulin elimination; antidiabetic agents |
| 01/20/2005 | US20050014687 Nucleoc acid sequences coding polypeptides; binding to antibodies; diagnosis, therapy of diseases such as cancer |
| 01/20/2005 | US20050014230 Generating immunoglobulin specific for human lymphadenopathy viral glycoprotein 120 for use in prevention and treatment of viral diseases; immunotherapy |
| 01/20/2005 | US20050014210 Ecstasy-class derivatives, immunogens, and antibodies and their use in detecting ecstasy-class drugs |
| 01/20/2005 | US20050014191 Transmembrane proteins for use in identifying modulator for treatment of inflammatory, splenic, bone, respiratory and cell proliferative disorders |
| 01/20/2005 | US20050014187 Novel polypeptide hormone phosphatonin |
| 01/20/2005 | US20050013832 Transcutaneous immunization against papillomavirus with papillomavirus virus-like particles |
| 01/20/2005 | US20050013831 Obtained from neisseria meningitidis and commensal neisseria; broad spectrum protective immunity |
| 01/20/2005 | US20050013828 Chimeric antigens for eliciting an immune response |
| 01/20/2005 | US20050013826 Administering modified protein having disruptive element located in internal region; enhancing ubiquitin proteasome system degradation; effective, long term T cell response |
| 01/20/2005 | US20050013825 Vaccine containing the catalytic subunit of telomerase for treating cancer |
| 01/20/2005 | US20050013824 Use of highly Immunodominant central nervous system myelin protein; inducing tolerance |
| 01/20/2005 | US20050013823 Administering to animal at 3 to 10 days of age; swine |
| 01/20/2005 | US20050013821 Mint extract and related pharmaceutical compositions |
| 01/20/2005 | US20050013815 Prevention and treatment of amyloidogenic disease |
| 01/20/2005 | US20050013814 Methods for treating rheumatoid arthritis using IL-17 antagonists |
| 01/20/2005 | US20050013812 Infectious diseases, allergies, cancer; kits |
| 01/20/2005 | US20050013811 Enhancement of immune responses by 4-1bb-binding agents |
| 01/20/2005 | US20050013810 Regulating immune response using dendritic cells |
| 01/20/2005 | US20050013800 Inhibiting ligand/receptor interactions involving immunoglobulins, interleukins, interferon-alpha, histamine and/or leukotrienes; long term relief; kits |
| 01/20/2005 | US20050013799 Using combination of IgE immunoglobulin inhibitor and antihistamine; kits |
| 01/20/2005 | US20050013796 Detection and treatment of breast disease |
| 01/20/2005 | DE10330235A1 Neues Eimeria Gen und Protein sowie deren Verwendung New Eimeria gene and protein and their use |
| 01/20/2005 | CA2541753A1 Combination therapy for gastroenteric diseases caused by microorganisms |
| 01/20/2005 | CA2532196A1 Characterization of the earliest stages of the severe acute respiratory syndrome (sars) virus and uses thereof |
| 01/20/2005 | CA2532173A1 Antibodies against insulin-like growth factor i receptor and uses thereof |
| 01/20/2005 | CA2531627A1 Autologous self-tolerance inducing cells of monocytic origin and their use in pharmaceutical preparations |
| 01/20/2005 | CA2531283A1 Specific human antibodies |